Updates on ISO 14155 and N=1 Therapeutics Discussed by TGA
Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.
Primary source: Download medicine data | European Medicines Agency (EMA)
The ASR module in the CTIS becomes mandatory for submitting Annual Safety Reports for clinical trials, requiring compliance with new submission protocols established under Regulation (EU) No 536/2014.
This change impacts clinical trial sponsors as they are required to adapt their safety reporting workflows to ensure compliance with the new mandatory channel for ASR submissions.
Clinical trial sponsors must update internal standard operating procedures (SOPs), conduct staff training on the functionality of the new ASR module, and utilize the CTIS training environment to ensure readiness for compliance with the new workflow.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Introduction of a dedicated ASR safety module in CTIS; transition to a mandatory submission channel for ASRs; updated functionalities for managing safety reporting in the system; new process for accessing the CTIS training environment.
Clinical trial sponsors must prepare for the mandatory transition to the CTIS ASR module for safety report submissions. PV operations and clinical safety teams will need to update internal SOPs, train staff on the new module's functionalities, and use the CTIS training environment to ensure compliance with the new submission workflow.
Clinical trial sponsors must update internal standard operating procedures (SOPs), conduct staff training on the functionality of the new ASR module, and utilize the CTIS training environment to ensure readiness for compliance with the new workflow.
The new ASR module will be the required method for submitting and managing Annual Safety Reports, analogous to Development Safety Update Reports (DSURs). This transition necessitates that clinical trial sponsors prepare by updating internal procedures and training staff on the new system functionalities.
What changed: The ASR module in the CTIS becomes mandatory for submitting Annual Safety Reports for clinical trials, requiring compliance with new submission protocols established under Regulation (EU) No 536/2014.
Why it matters: This change impacts clinical trial sponsors as they are required to adapt their safety reporting workflows to ensure compliance with the new mandatory channel for ASR submissions.
Practical implication: Clinical trial sponsors must update internal standard operating procedures (SOPs), conduct staff training on the functionality of the new ASR module, and utilize the CTIS training environment to ensure readiness for compliance with the new workflow.
Published from the Firecrawl policy change extraction pipeline.
Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.
Safety lead to: (1) perform a UK-clinical-trial safety reporting gap assessment against MHRA’s effective guidance sections (MedDRA coding; AE/SAE; RSI governance; SUSARs; annual safety reporting; USMs; serious breaches; temporary suspension), (2) update controlled SOPs/WIs and training records to reflect “effective” status as of 28 Apr 2026, and (3) document deviations/gaps and open CAPA where needed for ongoing UK trials and new submissions.
Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.
Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.